WS Form 4: Director Mark C. Davis receives 5,836 restricted shares
Rhea-AI Filing Summary
Mark C. Davis, a director of Worthington Steel, Inc. (WS), received a grant of 5,836 restricted common shares on 09/26/2025 under the Worthington Steel, Inc. 2023 Equity Incentive Plan for Non-Employee Directors. The restricted shares were granted at a price of $0 and increased his reported beneficial ownership to 21,219 shares following the transaction. The restricted stock will vest on the date of the company’s next Annual Meeting of Shareholders provided Mr. Davis remains on the board. The Form 4 was signed by Joseph Y. Heuer as attorney-in-fact on 09/30/2025.
Positive
- Director received 5,836 restricted shares under the 2023 Equity Incentive Plan, increasing stake to 21,219 shares
- Vesting is tied to continued board service, which aligns director incentives with shareholder interests
- Transaction disclosed promptly on Form 4 with execution and filing dates included
Negative
- None.
Insights
TL;DR: Routine director restricted-stock grant aligns director incentives with shareholders; vesting tied to continued board service.
This filing documents a standard non-employee director equity award under the company's 2023 Equity Incentive Plan. The grant of 5,836 restricted shares at a $0 price is explicitly described and vests only if the director remains on the board until the next Annual Meeting, which supports retention and alignment without immediate transferability. There are no disclosures in the filing of accelerated vesting, cash payments, or derivative transactions. The change in beneficial ownership to 21,219 shares is clearly stated, enabling investors to track insider exposure.
TL;DR: Transaction is a non-cash equity grant to a director; disclosure is concise and procedural.
The Form 4 reports a non-derivative acquisition of 5,836 common shares by a director, recorded as an award of restricted stock pursuant to the 2023 Equity Incentive Plan for Non-Employee Directors. The document specifies the vesting condition tied to the next Annual Meeting and provides the post-transaction beneficial ownership total of 21,219 shares. No exercise prices, derivative positions, or disposals are reported. The filing appears procedural and limited in scope.